Hydrogenology
Source-linked study record

Therapeutic efficacy of infused molecular hydrogen in saline on rheumatoid arthritis: a randomized, double-blind, placebo-controlled pilot study

Ishibashi T et al. · Int Immunopharmacol. 2014;21(2):468–473.

HumanH₂-rich waterPublished 2014Source checked
Study record, not medical adviceThis record reports what the source states. It is not medical advice and does not establish that molecular hydrogen is effective, safe or appropriate for any person.
Quick summary

Study at a glance

Evidence type

Human

Population or model

Adults with rheumatoid arthritis

Intervention and dose

500 mL H₂-dissolved saline by intravenous drip daily · 1 ppm dissolved H₂.

Duration

Daily for 5 days; follow-up through 4 weeks

Reported result

DAS28 and several laboratory markers favored H₂ saline at four weeks; TNF-α did not change meaningfully. The sample was very small.

Main limitation

Twenty-four-person pilot, five-day intervention and mainly disease-score and biomarker outcomes. Financial support was reported as none; complete author-industry relationship extraction remains pending.

Evidence and classification

What kind of evidence is this?

Evidence type

Human

Reported design

Randomized double-blind placebo-controlled pilot trial

Research topic

Immune and inflammatory conditions

Administration form

H₂-rich water

Information not yet classified

Some editorial classification fields are still pending. The source-reported outcomes and result are shown below; Hydrogenology does not infer a positive or negative signal from prose automatically.

Reported in the source

Methods

Population or model

Adults with rheumatoid arthritis

Sample

24 participants: H₂ saline n=12; placebo saline n=12

Duration

Daily for 5 days; follow-up through 4 weeks

Intervention

500 mL H₂-dissolved saline by intravenous drip daily

Hydrogen form

H₂ dissolved in intravenous saline — not inhaled, not H₂-rich drinking water and not Brown’s gas.

Dose or H₂ specification

1 ppm dissolved H₂.

Comparator

500 mL placebo saline by intravenous drip

Reported, not endorsed

Outcomes and reported result

Outcomes measured

DAS28, IL-6, TNF-α, MMP-3 and urinary 8-OHdG

Reported result

DAS28 and several laboratory markers favored H₂ saline at four weeks; TNF-α did not change meaningfully. The sample was very small.

Extraction completeness

Abstract and licensed full-text copy checked for methods and principal results; independent appraisal and complete conflict extraction remain incomplete.

A reported association, difference or mechanism is not automatically a clinical benefit.

Interpretation limits

Limitations and applicability

Main methodological cautions

Twenty-four-person pilot, five-day intervention and mainly disease-score and biomarker outcomes. Financial support was reported as none; complete author-industry relationship extraction remains pending.

Applies directly to

Adults with rheumatoid arthritis under supervised intravenous infusion; it does not inform drinking or inhalation protocols.

No single-study GRADE certainty rating is assigned. Read how records and evidence assessments are prepared.

Sources and status

Sources and record status

Identifiers

PMID: 24929023 · DOI: 10.1016/j.intimp.2014.06.001

Publisher access

The publisher identifies the article as open access under a Creative Commons license; a free full-text copy is available on ResearchGate.

Extraction basis

Licensed author-uploaded full text, publisher abstract and PubMed record.

Last reviewed

10 August 2026

Help the next reader

Help people check the facts before they buy.

Hydrogenology keeps 665 source-checked records accessible without advertising or product promotion.

Support independent access
Help us correct the recordReport a discrepancy

Send the exact difference between this page and the linked source. The study reference is attached automatically.